0
0Researchers have developed a multifunctional nanoplatform, known as MSM-DTM, designed to comprehensively treat tendinopathy by targeting the disease's core pathological components. This technology combines hybrid membrane vesicles—fused from macrophage and sensory neuron membranes—with a decellularized tendon matrix scaffold to create a pro-regenerative environment. The platform functions as a molecular sponge, effectively absorbing harmful inflammatory cytokines and pain-triggering neuropeptides to alleviate chronic discomfort. By inhibiting the abnormal activation of the JAK-STAT signaling pathway, the treatment successfully reverses cellular senescence in tendon stem cells and promotes functional tissue repair. In vivo studies using rat models demonstrated significant improvements in collagen organization, mechanical strength, and pain recovery compared to traditional treatments. Ultimately, this integrated strategy offers a promising alternative to current clinical methods by simultaneously addressing inflammation, tissue degeneration, and persistent pain.
References:
Li D, Huang W, Ni F, et al. A biomimetic hybrid membrane vesicle nanoplatform attenuates tendinopathy through neuroinflammation modulation and tendon regeneration[J]. Cell Reports Medicine, 2026.
